학술논문
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer.
Document Type
journal article
Author
Fernandez-Martinez, Aranzazu; Krop, Ian E.; Hillman, David W.; Polley, Mei-Yin; Parker, Joel S.; Huebner, Lucas; Hoadley, Katherine A.; Shepherd, Jonathan; Tolaney, Sara; Henry, N. Lynn; Dang, Chau; Harris, Lyndsay; Berry, Donald; Hahn, Olwen; Hudis, Clifford; Winer, Eric; Partridge, Ann; Perou, Charles M.; Carey, Lisa A.
Source
Journal of Clinical Oncology; 12/10/2020, Vol. 38 Issue 35, p4184-4193, 11p
Subject
Language
ISSN
0732183X